| Lastest Insider Transactions Of Allogene Therapeutics, Inc. ( ALLO ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R&D | 2026-01-21 | Sell | 26,269 | 1.56 | 40,980 | 2026-01-23 16:15:10 |
| ALLO | Allogene Therapeutics, Inc. | Kazam Joshua A | Directior | 2025-12-18 | Option Exercise | 47,700 | 0.00 | 0 | 2025-12-22 18:57:11 |
| ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 2025-11-17 | Sell | 786 | 1.22 | 959 | 2025-11-19 16:09:26 |
| ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | 2025-10-21 | Sell | 36,744 | 1.26 | 46,169 | 2025-10-23 18:20:44 |
| ALLO | Allogene Therapeutics, Inc. | MESSEMER DEBORAH M. | Directior | 2025-06-10 | Sell | 36,885 | 1.42 | 52,377 | 2025-06-12 16:18:31 |
| ALLO | Allogene Therapeutics, Inc. | Chang David D | President and CEO | 2025-03-14 | Sell | 46,668 | 1.96 | 91,469 | 2025-03-18 17:30:50 |
| ALLO | Allogene Therapeutics, Inc. | Beneski Benjamin Machinas | SVP, Chief Technical Officer | 2025-03-14 | Sell | 5,488 | 1.98 | 10,839 | 2025-03-18 17:28:04 |
| ALLO | Allogene Therapeutics, Inc. | MESSEMER DEBORAH M. | Directior | 2025-02-18 | Sell | 13,313 | 2.43 | 32,351 | 2025-02-20 16:15:28 |
| ALLO | Allogene Therapeutics, Inc. | Douglas Earl Martin | SVP, General Counsel | 2025-02-03 | Sell | 6,404 | 1.71 | 10,951 | 2025-02-05 16:16:37 |
| ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | 2025-02-03 | Sell | 4,361 | 1.73 | 7,545 | 2025-02-05 16:15:47 |
| ALLO | Allogene Therapeutics, Inc. | Chang David D | President and CEO | 2025-02-03 | Sell | 46,003 | 1.68 | 77,285 | 2025-02-05 16:13:43 |
| ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R&D | 2025-02-03 | Sell | 18,832 | 1.70 | 32,014 | 2025-02-05 16:12:55 |
| ALLO | Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R&D | 2025-01-21 | Sell | 27,199 | 1.78 | 48,414 | 2025-01-23 16:30:31 |
| ALLO | Allogene Therapeutics, Inc. | MESSEMER DEBORAH M. | Directior | 2024-12-09 | Sell | 9,136 | 2.18 | 19,916 | 2024-12-10 16:53:55 |
| ALLO | Allogene Therapeutics, Inc. | Humer Franz B | Directior | 2024-12-05 | Sell | 9,221 | 2.16 | 19,917 | 2024-12-09 16:05:52 |
| ALLO | Allogene Therapeutics, Inc. | MESSEMER DEBORAH M. | Directior | 2024-06-18 | Sell | 18,641 | 2.28 | 42,488 | 2024-06-20 16:31:35 |
| ALLO | Allogene Therapeutics, Inc. | Humer Franz B | Directior | 2024-05-30 | Sell | 11,200 | 2.34 | 26,181 | 2024-06-03 16:09:09 |
| ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Directior | 2024-05-16 | Buy | 1,724,137 | 2.90 | 4,999,998 | 2024-05-20 21:33:32 |
| ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CHIEF FINANCIAL OFFICER | 2024-01-30 | Buy | 190 | 3.60 | 683 | 2024-03-06 21:52:06 |
| ALLO | Allogene Therapeutics, Inc. | MESSEMER DEBORAH M. | Directior | 2023-12-18 | Sell | 18,640 | 2.70 | 50,317 | 2023-12-20 16:26:02 |
| ALLO | Allogene Therapeutics, Inc. | Mayo Stephen | Directior | 2023-08-07 | Sell | 10,000 | 4.29 | 42,855 | 2023-08-09 16:07:07 |
| ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | General Counsel | 2023-02-13 | Sell | 3,000 | 6.85 | 20,550 | 2023-02-14 17:10:36 |
| ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | General Counsel | 2023-01-17 | Sell | 3,000 | 7.04 | 21,120 | 2023-01-18 18:10:27 |
| ALLO | Allogene Therapeutics, Inc. | Bhavnagri Veer | General Counsel | 2022-12-15 | Sell | 5,602 | 7.53 | 42,186 | 2022-12-19 16:29:07 |
